Drug Delivery
Teva Pharmaceutical to take over MicroDose Therapeutx
By
Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise.
Drug Research > Drug Delivery > News
Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise.
Drug Research > Drug Delivery > News
Amgen's XGEVA receives FDA approval to treat giant cell tumor of bone
By
The US Food and Drug Administration (FDA) has given its clearance to Amgen's XGEVA (denosumab) to treat adult or skeletally mature patients suffering from giant cell tumor of bone (GCTB).
Drug Research > Drug Delivery > News Bristol-Myers Squibb, Simcere join hands to develop Orencia in China By
Bristol-Myers Squibb and Simcere Pharmaceutical Group have extended their collaboration to develop and commercialize the subcutaneous (SC) formulation of Bristol-Myers Squibb's biologic medicine, Orencia (abatacept), in China.
Drug Research > Drug Delivery > News
The US Food and Drug Administration (FDA) has given its clearance to Amgen's XGEVA (denosumab) to treat adult or skeletally mature patients suffering from giant cell tumor of bone (GCTB).
Drug Research > Drug Delivery > News Bristol-Myers Squibb, Simcere join hands to develop Orencia in China By
Bristol-Myers Squibb and Simcere Pharmaceutical Group have extended their collaboration to develop and commercialize the subcutaneous (SC) formulation of Bristol-Myers Squibb's biologic medicine, Orencia (abatacept), in China.
Drug Research > Drug Delivery > News
Latest Drug Delivery News and Insight
View all Drug Delivery news or find news targeted to your interests
ThromboGenics' Jetrea receives NICE approval for eye condition treatment
Biopharmaceutical company ThromboGenics' Jetrea has received approval from UK's National Institute for Health and Care Excellence (NICE) in the treatment of some adults with vitreomacular traction (VMT), a rare eye condition.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Daiichi Sankyo launches Pralia subcutaneous injection 60mg syringe
Daiichi Sankyo Company has launched Pralia subcutaneous injection 60mg syringe (generic name denosumab) for the treatment of osteoporosis, following its manufacturing and marketing approval in Japan.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Cumberland Pharma receives FDA approval for new labeling of Acetadote
Cumberland Pharmaceuticals has received the US Food and Drug Administration’s (FDA’s) approval for updated labeling of Acetadote (acetylcysteine) Injection, which is free from Ethylene diamine tetracetic acid (EDTA) or any other stabilization or chelating agents.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
FDA clears Sanofi Pasteur's four-strain influenza vaccine for wide age range
The US FDA has cleared Sanofi Pasteur's supplemental biologics license application (sBLA) licensing four-strain influenza vaccine, Fluzone Quadrivalent, for broad age range of children and adults.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
USPTO grants patent to GenSpera for activation of peptide prodrugs by HK2
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Genoa, McMaster University reveal findings of GP-101 in pulmonary fibrosis treatment
US-based inhaled medicines provider Genoa Pharmaceuticals in collaboration with McMaster University has demonstrated advantages of the inhaled aerosol pirfenidone (GP-101) in the treatment of pulmonary fibrosis.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Flexicon machine aids biotherapeutics development work at Cancer Research UK
A Flexicon FP50 tabletop filling and stoppering machine from Watson-Marlow Pumps Group has automated a previously manual process at a Cancer Research UK facility in Hertfordshire. The FP50 is delivering increased speed and reliability into this critical operation, as well as enhanced vial filling accuracy.
Drug Research > Drug Delivery > Press Releases
Drug Research > Drug Delivery > Press Releases
Sun Pharmaceutical's generic Depo-Testosterone Injection wins FDA approval
Specialty pharmaceutical company Sun Pharmaceutical Industries has obtained final USFDA approval for the abbreviated new drug application of generic Depo-Testosterone Injection, Testosterone Cypionate Injection USP, 100mg/ml and 200mg/ml.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
MannKind completes Phase 3 study of type 1 diabetes candidate
MannKind has completed the Phase 3 clinical study of Afrezza (insulin human [rDNA origin]) in patients with type 1 diabetes and expects to release the data in the summer of 2013.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Daiichi seeks approval for extended indication of Topotecin in Japan
Daiichi Sankyo Company has filed a supplemental new drug application for extended indication of anticancer agent Topotecin intravenous drip infusion 40mg, 100mg with the Japan's Ministry of Health, Labor and Welfare.
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests
Drug Research > Drug Delivery > News
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations
Buy online from $200
